Recently egressed effector CD8+ T cells maintain their ability to produce cytotoxic cytokines in response to ex vivo stimulation [80] and may represent a therapeutically-relevant pool of cytotoxic T cells with tumor killing potential. The gene discussed is CD8A; the disease is neoplasm.